Modeling inherited retinal diseases using human induced pluripotent stem cell derived photoreceptor cells and retinal pigment epithelial cells
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Induced pluripotent stem cell (iPSC) technology enables inherited retinal disease (IRD) modeling. This review provides a toolkit and discusses quality control for consistent and reliable iPSC-derived IRD models.
Area Of Science
- Stem cell biology
- Ophthalmology
- Genetics
Background
- Induced pluripotent stem cell (iPSC) technology has revolutionized disease modeling.
- Cellular models of inherited retinal diseases (IRDs) are crucial for understanding pathogenesis and drug discovery.
- Consistency and quality control are critical for the utility of iPSC-derived disease models but are often overlooked.
Purpose Of The Study
- To provide a comprehensive toolkit for generating iPSC-derived photoreceptor, retinal pigment epithelial cell, and organoid models of IRDs.
- To discuss key considerations for developing robust and reproducible iPSC-based IRD models.
- To review current methods, identify scientific hurdles, and outline future directions in iPSC-based IRD modeling.
Main Methods
- Review of existing literature and methodologies for iPSC derivation and differentiation.
- Analysis of quality control metrics and strategies for iPSC-based disease modeling.
- Dissection of various iPSC-derived IRD models and their applications.
Main Results
- A toolkit for generating iPSC-derived photoreceptor, RPE, and organoid models is presented.
- Essential considerations including iPSC origin, reprogramming, quality control, controls, and differentiation are discussed.
- Current iPSC-based IRD models are analyzed, highlighting their strengths and limitations.
Conclusions
- Standardized quality control metrics are essential for advancing the reliability of iPSC-derived IRD models.
- Addressing scientific hurdles in iPSC-based disease modeling will accelerate target discovery and validation for IRDs.
- This review offers a roadmap for harnessing iPSC technology to create effective cellular models for inherited retinal diseases.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
iPSCs have been successfully used to treat age-related macular degeneration (AMD), a form of...